Total Payments
$2,056
2024 Payments
$371.03
Companies
12
Transactions
55
Medicare Patients
3,857
Medicare Billing
$840,661
Payment Breakdown by Category
Food & Beverage$1,842 (89.6%)
Other$150.00 (7.3%)
Education$63.94 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,842 | 52 | 89.6% |
| Honoraria | $150.00 | 1 | 7.3% |
| Education | $63.94 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $487.86 | 10 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $399.17 | 8 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $206.73 | 3 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $199.90 | 9 | $0 (2024) |
| Travere Therapeutics, Inc. | $137.43 | 6 | $0 (2024) |
| Amgen Inc. | $122.10 | 1 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $120.99 | 6 | $0 (2018) |
| Relypsa, Inc. | $115.11 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $102.95 | 1 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $82.19 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.03 | 15 | Aurinia Pharma U.S., Inc. ($131.46) |
| 2023 | $212.19 | 5 | Amgen Inc. ($122.10) |
| 2021 | $275.45 | 3 | Alexion Pharmaceuticals, Inc. ($150.00) |
| 2020 | $19.78 | 1 | Otsuka America Pharmaceutical, Inc. ($19.78) |
| 2019 | $399.20 | 6 | Otsuka America Pharmaceutical, Inc. ($304.67) |
| 2018 | $753.86 | 24 | Mallinckrodt LLC ($304.64) |
| 2017 | $24.42 | 1 | Relypsa, Inc. ($24.42) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.73 | General |
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEPHROLOGY | ||||||
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $32.91 | General |
| 10/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.14 | General |
| 08/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Rare Disease | ||||||
| 07/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/20/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $59.00 | General |
| Category: Wound Care | ||||||
| 06/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/13/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: NEPHROLOGY | ||||||
| 05/25/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $28.14 | General |
| 03/01/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/09/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.86 | General |
| 12/08/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.65 | General |
| 08/29/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/11/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/16/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/09/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $122.10 | General |
| Category: Inflammation | ||||||
| 09/10/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Hyperkalemia | ||||||
| 08/19/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 07/14/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEPHROLOGY | ||||||
| 11/11/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $102.73 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 518 | 883 | $457,692 | $102,916 |
| 2022 | 14 | 1,035 | 1,966 | $433,572 | $222,822 |
| 2021 | 15 | 1,141 | 2,247 | $508,867 | $263,241 |
| 2020 | 15 | 1,163 | 2,282 | $535,092 | $251,682 |
Total Patients
3,857
Total Services
7,378
Medicare Billing
$840,661
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 29 | 79 | $84,246 | $22,412 | 26.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2023 | 15 | 65 | $124,410 | $19,339 | 15.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 230 | $47,694 | $15,133 | 31.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 106 | $36,371 | $10,683 | 29.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 62 | 125 | $48,907 | $7,455 | 15.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 28 | $27,046 | $6,648 | 24.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $20,452 | $5,519 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 50 | $24,204 | $5,497 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 59 | $10,266 | $3,902 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 36 | $19,224 | $2,914 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 56 | $6,776 | $2,336 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $8,096 | $1,078 | 13.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 43 | 199 | $103,281 | $59,592 | 57.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 233 | 585 | $67,860 | $35,051 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 209 | $36,366 | $21,168 | 58.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 100 | 229 | $38,243 | $19,721 | 51.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 13 | 78 | $33,696 | $18,724 | 55.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 123 | 139 | $30,858 | $15,658 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 216 | $26,136 | $14,590 | 55.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 29 | 56 | $24,192 | $13,732 | 56.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 70 | $22,680 | $11,688 | 51.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 51 | 77 | $32,725 | $4,702 | 14.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 15 | 19 | $8,550 | $3,520 | 41.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 50 | 58 | $2,610 | $1,623 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,915 | $1,581 | 54.2% |
About Dr. Ivan Begov, MD
Dr. Ivan Begov, MD is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578719993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Begov, MD has received a total of $2,056 in payments from pharmaceutical and medical device companies, with $371.03 received in 2024. These payments were reported across 55 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,842).
As a Medicare-enrolled provider, Begov has provided services to 3,857 Medicare beneficiaries, totaling 7,378 services with total Medicare billing of $840,661. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Chicago, IL
- Active Since 08/18/2008
- Last Updated 04/04/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1578719993
Products in Payments
- JYNARQUE (Drug) $409.70
- ACTHAR (Biological) $399.17
- LUPKYNIS (Drug) $199.90
- Soliris (Drug) $150.00
- Veltassa (Drug) $137.61
- TAVNEOS (Drug) $122.10
- Auryxia (Drug) $120.99
- FARXIGA (Drug) $102.95
- SAMSCA (Drug) $78.16
- Rayaldee (Drug) $62.10
- Kerecis Omega3 SurgiClose (Device) $59.00
- SOLIRIS (Drug) $35.43
- ULTOMIRIS (Biological) $21.30
- Rayaldee (old) (Drug) $20.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chicago
Nicole Stankus
Nephrology — Payments: $241,812
Nephrology $241,812
Susan Quaggin, Md, MD
Nephrology — Payments: $235,919
Nephrology $235,919
Lorenzo Gallon, Md, MD
Nephrology — Payments: $187,956
Nephrology $187,956
John Friedewald, Md, MD
Nephrology — Payments: $131,619
Nephrology $131,619
Arlene Chapman
Nephrology — Payments: $125,467
Nephrology $125,467
Dr. Jay Koyner, M.d, M.D
Nephrology — Payments: $87,521
Nephrology $87,521